Long Term Experience With Abatacept in Routine Clinical Practice
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the retention rate of Abatacept over 24 months in
routine clinical practice in every participating country depending on the treatment line.